B[National Medical Insurance Bureau convened a symposium of surgical robot experts] September 11th, according to the National Medical Insurance Bureau, on the morning of September 11, the National Medical Insurance Bureau organized a symposium of surgical robot experts. Huake Precision, Shanghai MicroPort, Medtronic, and Intuitive Fosun Representatives from seven domestic and foreign surgical robot manufacturers including Shenzhen Jingfeng, Beijing Tianzhihang, and Stryker, and representatives from five hospitals including Guangdong Provincial People's Hospital, Peking University People's Hospital, Beijing Tiantan Hospital, Jishuitan Hospital, and Beijing Tongren Hospital participated in the discussion and exchange. Everyone generally agrees that the current functions of surgical robots need to continue to expand, from highly concentrated fields such as urology, orthopedics, and general surgery, to more precise efforts in areas such as brain surgery and interventional surgery, and to seamlessly integrate with the rapidly developing brain-computer interface technology to maximize the technical advantages of surgical robots. Surgical robots must also keep pace with cutting-edge technologies such as intelligent robots and artificial intelligence, constantly learn from good experiences in the use of robots in other fields, further enrich the scenarios for the use of surgical robots, and boldly imagine, carefully verify, and actively advance toward the goal of autonomous automation of some or all functions. B[Zhang Ke, Director of the National Medical Insurance Administration, is in Beijing to investigate medical security work] September 10th, Zhang Ke, Secretary of the Party Leadership Group and Director of the National Medical Insurance Administration, is in Beijing to investigate medical security work. Zhang Ke pointed out that it is necessary to continue to improve the level of primary medical security services, make good use of medical insurance "door-to-door service fees" and "family hospital bed construction fees" and other price policies to encourage medical institutions to extend services to patients' families, so that the elderly and disabled patients can receive inclusive and convenient medical care. It is necessary to vigorously promote the centralized procurement of drugs into grassroots medical institutions, private medical institutions, and retail pharmacies to ensure that good drugs with high quality and low price can reach the people directly. It is necessary to accelerate the construction of a diversified and convenient payment system of face payment, one-code payment, mobile payment, and credit payment, covering all scenarios of outpatient and inpatient medical treatment, and adapting to the convenient payment needs of different people.
Zhang Ke emphasized that medical insurance departments at all levels across the country should support the large-scale application of major innovations in the pharmaceutical field based on functions such as medical insurance price establishment, medical insurance fund payment, and medical insurance big data management. In particular, the capital's medical insurance department must have forward-looking strategic thinking and continuously cultivate and expand emerging industries and future industries in medical insurance-related fields. On the basis of promoting the rational use of surgical robots, remote surgery, and automatic surgery, we must promote the standardized uploading and collection of data such as the medical insurance imaging cloud, the medical insurance pathology cloud, and the use of surgical robots, and make good use of the data while ensuring that the data is safe and does not leave the domain and is available and invisible to promote the development of new medical productivity. B[The core grouping of version 3.0 of payment by disease has increased to 492 groups, highlighting the "one old and small" and innovative support] On September 2, Yan Bing, deputy director of the Beijing Municipal Medical Insurance Bureau and leader of the DRG technical guidance group, introduced at a press conference on the grouping plan of version 3.0 of payment by disease held today that version 3.0 of payment by disease generally presents the characteristics of "clearer guidance, more refined grouping, and standards that are more in line with reality." Version 3.0 has five main changes compared to version 2.0: First, the grouping is more refined, with the core grouping increasing from 409 to 492, subdivisions increasing from 634 to 825, and rehabilitation, pain, therapeutic operations and difficult combined operations being further subdivided; secondly, paying more attention to "one old and one young", adding new subdivisions for cases under 6 years old and over 70 years old, and painless delivery. It is set to three independent payment groups; the third is to more clearly support medical innovation and set up separate groups for surgical robot-assisted surgeries; the fourth is to further optimize the grouping logic to be more in line with clinical reality; the fifth is to streamline the list of comorbidities and complications, with nearly 3,000 fewer severe comorbidities and complications compared with version 2.0, and about 1,500 fewer general comorbidities and complications. (Reporter Lu Afeng)
— All loaded —
